drugset / Trial / NCT04403139
VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination
Phase 4
Active not recruiting
50 enrolled
University of Washington
National Institute on Aging (NIA) · collab
Non-randomizedSingle-groupOpen-labelBasic science
Summary
To evaluate the effect of intramuscular RZV vaccine on VZV-specific skin TRM and circulating T-cells
Timeline
- Start
- 2022-04-27
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VARICELLA ZOSTER VIRUS ENVELOPE GLYCOPROTEIN E | Vaccine | — | Intramuscular |